XML 42 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Strategic Alliances and Collaborations (Tables)
 12 Months Ended
Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Revenue from Strategic Alliances
The following table summarizes our total revenues from our strategic alliances and collaborations during the periods presented (in thousands):
 
 
Year ended December 31,
 
2015
 
2014
 
2013
AstraZeneca
$
18,871

 
$
1,859

 
$
1,859

Sanofi
71

 
979

 
15,336

GSK
—

 
3,509

 
1,778

Biogen
1,817

 
1,122

 
596

Other
—

 
200

 
—

Total
$
20,759

 
$
7,669

 
$
19,569